Response to Foslevodopa/Foscarbidopa by Sex: Post Hoc Analyses of 2 Phase 3 Clinical Studies (P11-5.013)

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000208596
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Response to Foslevodopa/Foscarbidopa by Sex: Post Hoc Analyses of 2 Phase 3 Clinical Studies (P11-5.013)

Manon Bouchard, Per Odin, Drew S. Kern, Lars Bergmann et al.
Neurology
Multiple Sclerosis Research Studies
article

Response to Foslevodopa/Foscarbidopa by Sex: Post Hoc Analyses of 2 Phase 3 Clinical Studies (P11-5.013)

Manon Bouchard, Per Odin, Drew S. Kern, Lars Bergmann, Irene A. Malaty, Okeanis Vaou, Tove Henriksen, Resmi Gupta, Megha Shah, Marie O’Meara
article en

Abstract

No abstract available for this paper.
NeurologyVol. 104(7_Supplement_1)
The University of Texas at San Antonio Health Science Center (US), Lund University (SE), Bispebjerg Hospital (DK), AbbVie (United States) (US), University of Florida (US), University of Colorado Denver (US)
Gender equality
Openalex Percentile: Top 90%
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.